Abstract
Cell-based screens represent one of the most venerable approaches to lead generation, indeed, antimicrobial screens were the mainstay of drug discovery in the 1940s, 1950s, and 1960s (1). However, cellular assays also represent one of the most dynamic areas of innovation in high-throughput screening (HTS). The driver of this innovation is the demand for more leads from more complex targets. Genomics discovery efforts have generated many potential targets for HTS, but the biochemical nature of these novel targets may not be elucidated prior to their entry into the lead generation process. Therefore, these targets are frequently addressed in “gene to screen” paradigms that rely on cellularscreening approaches. Advances in cell-based screening approaches have also been driven by the need to address complex, multi-component target classes that may not be feasible in biochemical assays. Finally, the increasingly combative intellectual property playing field, and the need to accelerate the drug discovery process have driven innovations in cell-based screening methodologies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Drews J. (2000) Drug discovery: a historical perspective. Science 287, 1960–1964.
Martin M. J., Dekisi J. L., Bennett H. M. (1998) Drug target validation and identification of secondary drug targets using microarrays. Nature Med. 4, 1293–1301.
Klein R. D. and Geary T. G. (1997) Recombinant microorganism as tools for high throughput screening for nonantibiotic compounds. J. Biomol. Screening 2, 41–49.
Beydon M., Fournier A., Drugenult L., et al. (2000) Microbiological high throughput screening, an opportunity for the lead discovery process. J. Biomol. Screening 5, 13–21.
Rice J. W., Davis J. E., Crowl R. M., et al. (1996) Development of a high volume screen to identify inhibitors of endothelial cell activation. Anal. Biochem. 241, 254–259.
Drake, Ajayi A., Lowe S. R., et al., (1998) Desensitization of CGRP and adrenomedullin receptors in SK-N-MC cells: implications for the RAMP hypothesis. Endocrinology 140, 533–537.
Clarke S. A., Quande C., Constandy H., et al. (1997) Novel insulinoma cell lines produced by iterative engineering of glut2, glukokinase, and human insulin expression. Diabetes 46, 958–967.
Yaffe D. and Saxel O. (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270, 725–727.
Koren H. S., Anderson S. J., and Larrick J. W. (1979) In vitro activation of a human macrophage-like cell line. Nature 279, 328–331.
Yaffe D. (1968) Retention of differentiation potentialities during prolonged cultivation of myogenic cells. PNAS 61, 477–483.
Dhundale A. and Goddard C. (1996) Reporter assays in the high throughput screening laboratory; a rapid and robust first look. J. Biomol. Screening 1, 115–118.
Zlokarnik G., Negulescu P. A., Knapp T. E., et al. (1998) Quantitation of transcription and clonal selection of single living cells with beta-lactamase reporter. Science 279, 84–88.
Comley J., Reeves T., and Robinson P. (1998) A 1536 colorimetric SEAP reporter assay: comparison with 96-and 384 well formats. J. Biomol. Screening 3, 217–226.
George S., Bungay P., and Naylor L. (1997) Evaluation of a CRE-directed luciferase reporter gene assay as an alternative to measuring cAMP accumulation. J. Biomol. Screening 4, 235–240.
Dolmetsch R. E., Lewis R. S., Goodnow C. C., et al. (1997) Differential activation of transcription factors induced by Ca+2 response amplitude and duration. Nature 386, 855–858.
Schroeder K. and Neagle B. S. (1996) FLIPR: a new instrument for accurate, high throughput optical screening. J. Biomol. Screening 1, 75–80.
Minta A., Kao J. P., and Tsien R. Y. (1989) Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores. J. Biol. Chem. 264, 8171–8178.
Offermans S. and Simon M. I. (1995) G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C. J. Biol. Chem. 270, 15,175–15,180.
DeWit et al. (1998) Large scale screening assay for the phosphorylation of mitogen-activated protein kinase in cells. J. Biomol. Screening 3, 277–284.
Surry D., McAllister G., Meneses-Lorente G., et al. (1999) High throughput ribonuclease protection assay for the determination of CYP3A mRNA induction in cultured rat hepatocytes. Xenobiotica 8, 827–838.
Hahn S. E., Yu M., Tong S., et al. (1999) Development of an in vitro screening assay for compounds that increase bone formation. J. Biomol. Screening 4, 363–371.
Conway, Minor L. K., Xu J. Z., et al. (1999) Quantification of G-protein coupled receptor internalization using G-protein coupled receptor-green fluorescent protein conjugates with the ArrayScan high-content screening system. J. Biomol. Screening 4, 75–86.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc.
About this protocol
Cite this protocol
Johnston, P. (2002). Cellular Assays in HTS. In: Janzen, W.P. (eds) High Throughput Screening. Methods in Molecular Biology™, vol 190. Humana Press. https://doi.org/10.1385/1-59259-180-9:107
Download citation
DOI: https://doi.org/10.1385/1-59259-180-9:107
Publisher Name: Humana Press
Print ISBN: 978-0-89603-889-9
Online ISBN: 978-1-59259-180-0
eBook Packages: Springer Protocols